Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP809155.RAVJJzcSt4c1LU4fiMslxSuEes5uqb6npqVjt29NRbndI130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP809155.RAVJJzcSt4c1LU4fiMslxSuEes5uqb6npqVjt29NRbndI130_assertion type Assertion NP809155.RAVJJzcSt4c1LU4fiMslxSuEes5uqb6npqVjt29NRbndI130_head.
- NP809155.RAVJJzcSt4c1LU4fiMslxSuEes5uqb6npqVjt29NRbndI130_assertion description "[Risk-reducing salpingo-oophorectomy (RRSO) is often recommended to carriers of deleterious breast cancer gene 1/2 (BRCA1/2) mutations in order to reduce their breast cancer risk by 50% and their ovarian cancer risk by approximately 95%.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP809155.RAVJJzcSt4c1LU4fiMslxSuEes5uqb6npqVjt29NRbndI130_provenance.
- NP809155.RAVJJzcSt4c1LU4fiMslxSuEes5uqb6npqVjt29NRbndI130_assertion evidence source_evidence_literature NP809155.RAVJJzcSt4c1LU4fiMslxSuEes5uqb6npqVjt29NRbndI130_provenance.
- NP809155.RAVJJzcSt4c1LU4fiMslxSuEes5uqb6npqVjt29NRbndI130_assertion SIO_000772 20428881 NP809155.RAVJJzcSt4c1LU4fiMslxSuEes5uqb6npqVjt29NRbndI130_provenance.
- NP809155.RAVJJzcSt4c1LU4fiMslxSuEes5uqb6npqVjt29NRbndI130_assertion wasDerivedFrom befree-2016 NP809155.RAVJJzcSt4c1LU4fiMslxSuEes5uqb6npqVjt29NRbndI130_provenance.
- NP809155.RAVJJzcSt4c1LU4fiMslxSuEes5uqb6npqVjt29NRbndI130_assertion wasGeneratedBy ECO_0000203 NP809155.RAVJJzcSt4c1LU4fiMslxSuEes5uqb6npqVjt29NRbndI130_provenance.